Every modern CPAP carries a comfort feature that drops the pressure a couple of centimetres of water at the start of expiration and returns it to therapeutic level before the next inspiration begins. ResMed calls this EPR (Expiratory Pressure Relief). Philips calls it Flex — with three flavours, C-Flex, C-Flex+, and A-Flex. BMC labels it EPR directly. A growing number of Chinese-OEM CPAPs marketed in India use a composite name like “EPFlex” on the box and in the UI — a portmanteau built for search-engine relevance rather than engineering precision. The underlying mechanism is the same across all of them, and the clinical benefit is, honestly, modest.
This article walks through what these features actually do, where they differ, when to enable them, and when to switch them off. It also pulls apart a persistent myth: that expiratory pressure relief reduces residual AHI. It does not. Its value — where there is any — is comfort and adherence, not event control.
What the feature physically does
A CPAP maintains a therapeutic pressure at the mask throughout the breath cycle. The therapeutic pressure is set either by the physician (fixed CPAP) or by the auto-algorithm (APAP). When a patient exhales against that pressure, they are exhaling against a pressure gradient they did not encounter before starting therapy. For some patients this feels unnatural, especially in the first few weeks of therapy and at higher pressure prescriptions (roughly 12 cmH₂O and above).
Expiratory pressure relief drops the delivered pressure by a clinician-settable amount — typically 1, 2, or 3 cmH₂O — at the onset of expiration, then ramps the pressure back up to the therapeutic level before the next inspiration. The drop is very short: the low-pressure window is perhaps 500 ms at the peak of expiratory flow, and the blower is already ramping back up well before the patient begins inhaling.
Implementations differ in how the ramp-down and ramp-up are shaped:
- ResMed EPR: a roughly linear drop at expiration onset, a brief hold, then a linear return to pressure. Settings are 1, 2, or 3 cmH₂O. EPR can be configured to run only during the ramp period (the first 10–30 minutes after therapy starts) or throughout the night.
- Philips C-Flex: a pressure reduction proportional to the patient’s expiratory flow. More flow (early expiration) produces more reduction; late expiration, as flow falls, sees pressure already rising again. Settings are 1, 2, or 3 — not strictly cmH₂O but a device-internal scaling.
- Philips C-Flex+: C-Flex plus a small inspiratory pressure smoothing to make the transition from expiration-low to inspiration-high feel less abrupt.
- Philips A-Flex: only available in APAP mode. Adds a mild expiratory pressure reduction similar to C-Flex, plus an inspiratory shape smoothing that takes the edge off the pressure rise at the start of each breath.
- BMC EPR: functionally equivalent to ResMed EPR with 1–3 cmH₂O settings; the ramp shape is slightly different but the intent matches.
- Generic “EPFlex” (Chinese OEM): a marketing compound. Under the hood, the device runs an EPR-class algorithm, usually with settings of 1, 2, or 3. The “Flex” suffix is not an engineering claim — it’s an SEO claim. Do not read any clinical implication into it.
The key physical point: the pressure at expiration does not drop by much, and it does not drop for long. A patient who says “EPR makes exhaling much easier” is reporting a real perceptual improvement, but the mechanical work-of-breathing reduction is small — on the order of a few percent of total expiratory work, not the dramatic reduction some of the marketing copy implies.
Why the clinical benefit is small
A common misconception is that expiratory pressure relief reduces residual AHI. It does not. The algorithms that detect and prevent obstructive events need a therapeutic pressure at the upper-airway level to keep the airway splinted. Dropping pressure during expiration for 500 ms does not materially change airway patency — the airway stays open because the pressure returns quickly enough that no event window opens. If anything, aggressive expiratory relief settings can, in pressure-sensitive patients, slightly increase the AHI by briefly un-splinting the airway at the top of expiration.
What EPR and Flex do offer is a modest, real improvement in comfort at high pressures. Published adherence data from manufacturer-sponsored trials and independent re-analyses suggest that EPR-equivalent features are associated with a small increase in adherence — somewhere between nothing and a few percentage points on the 4-hours-per-night metric. This is not nothing, but it is small, and it is dwarfed by the adherence effect of correct mask fit, proper humidification, and patient education.
The AHI that CPAP reduces is driven by the therapeutic pressure, the auto-algorithm’s pressure response, the mask seal, and patient factors like supine sleep and alcohol. Expiratory pressure relief is a comfort layer on top of that, not a therapeutic lever. When a patient asks, “Will EPR improve my AHI?” the honest answer is “No, and it may slightly worsen it. Leave it on if it helps you sleep; switch it off if you’re adherent without it.”
Pressure curves and residual AHI
Taking a step back: on a good night, a patient on CPAP with EPR at 3 cmH₂O has a pressure tracing that oscillates between the therapeutic level during inspiration and roughly 3 cmH₂O below it for a short window during expiration. If the therapeutic level is 10 cmH₂O, the expiratory nadir is near 7 cmH₂O. For most adults with uncomplicated OSA, 7 cmH₂O at expiration onset is still plenty to hold the airway open — the airway is widest at end-inspiration and tends to remain open until well into expiration in any case. For a patient at a high prescribed pressure (16 cmH₂O, say, for severe pressure-sensitive OSA), 13 cmH₂O at expiratory nadir is likewise fine.
The group where expiratory pressure relief can subtly increase residual AHI is a narrow one: patients with severe positional or REM-dependent OSA whose airway closes readily during expiration if unsplinted. In these patients, a sleep physician may see the residual AHI tick up by 0.5–1.5 events per hour when EPR is enabled at 3 versus 0. The fix is straightforward: either drop EPR to 1 or 0, or accept the small AHI bump in return for the comfort benefit. This is a clinical judgement and should be made against the individual patient’s titration data.
When to enable expiratory pressure relief
A practical set of rules:
- Enable at 2–3 during the first 4–8 weeks. A newly diagnosed patient initiating CPAP is learning to breathe against a novel pressure profile. Expiratory relief makes that less strange and less likely to trigger the “I can’t exhale against this” reaction that drives early dropouts.
- Enable if the prescription is ≥ 12 cmH₂O. Higher pressures produce more subjective expiratory effort. The comfort benefit scales with pressure.
- Enable if the patient reports aerophagia. Swallowing air during sleep is more common at high CPAP pressures; a lower expiratory pressure can reduce swallowing-triggered gas ingestion.
- Enable if the patient is a nasal mask user with complaints of dry mouth or mask-leak-at-exhalation. Lower expiratory pressure reduces leak and therefore reduces mouth drying.
When to switch it off
- Disable in patients with a known sensitivity to pressure oscillation. A small subset of patients report that the pressure drop and return pattern is perceptible as a “pulsing” sensation and is itself arousing.
- Disable in patients with central sleep apnea or complex sleep apnea. Expiratory pressure relief can subtly destabilise the breath-to-breath pattern and, in patients with central event predominance, can increase event frequency. Residual AHI monitoring after a change is the right check.
- Disable on advice from a sleep physician reviewing titration data. If the titration showed an AHI tick-up with EPR on, respect that call.
- Disable in a stable, adherent patient who doesn’t report comfort benefit. Features that do not deliver benefit are just features that consume device processing and complicate interpretation of the report.
The marketing-versus-engineering distinction
A Chinese-OEM CPAP box that reads “EPFlex” is claiming compatibility with a general class of comfort algorithm. It is not claiming feature parity with ResMed EPR or Philips C-Flex. In practice, the implementations vary:
- Some generic implementations use a simple two-point drop-and-hold at fixed pressure reduction.
- Some use a flow-proportional drop, as Philips does.
- Some use a fixed drop with a timing that ignores the patient’s actual expiratory flow, which produces inconsistent comfort.
For clinicians and patients in India evaluating a budget CPAP, the questions to ask are:
- What is the stated pressure-reduction range? (1, 2, 3 cmH₂O is the expected range; devices that claim “up to 5” should be viewed with scepticism — the airway un-splinting risk is real at those levels.)
- Does the device log the expiratory pressure it actually delivered? (Philips and ResMed log this; many generic devices do not.)
- Is there an option to disable the feature entirely? (Some generic devices tie it to the auto-ramp function, so disabling one disables the other — a design compromise.)
What we recommend in routine practice
For a typical adult patient initiating CPAP in India:
- Start with expiratory pressure relief at 2 during the first month.
- Review at 30 days. If the patient is adherent and comfortable, keep it at 2 or reduce to 1. Reducing slowly avoids the transient discomfort of switching it off abruptly.
- If the patient reports no comfort benefit at a 30-day review, switch it off and compare a week of data with/without. The expected change in residual AHI is small in either direction.
- For a patient on APAP with a high pressure ceiling (≥ 16 cmH₂O), keep expiratory pressure relief at 2–3 indefinitely.
- For a patient with complex or central sleep apnea, default off.
The bottom line
Expiratory pressure relief is a real feature. It does a small, real thing. It matters for comfort in some patients and does not matter in others. Its relationship to residual AHI is neutral-to-slightly-negative, and it should never be positioned — by a manufacturer or a clinician — as a treatment-efficacy feature.
The single largest driver of CPAP benefit remains, stubbornly, adherence. Mask fit, humidification, patient education, and follow-up matter an order of magnitude more than whether the expiratory pressure drops 1 versus 3 cmH₂O for a third of a second. Patients shopping for a CPAP in India should weight the expiratory pressure relief setting lightly, pay attention to service network and follow-up support heavily, and reserve the “is EPR on?” question for their titration review rather than their device-purchase decision.
Consult your sleep physician if you are unsure what expiratory pressure relief setting to use.
References: AASM CPAP titration guidance; ResMed and Philips technical white papers on EPR and Flex; Bakker et al, Sleep Med Rev 2011; independent adherence re-analyses cited above [CITATION].